Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial

Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The latest screenshot shows cosmetic/layout updates to the study page, with sections and navigation reorganized but all substantive content (dates, enrollment, inclusion/exclusion criteria, outcomes, and locations) remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:14:26.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Added a prominent government funding status notice and an updated version tag (v3.2.0) while removing the old version tag (v3.1.0).
    Difference
    4%
    Check dated 2025-10-05T10:16:00.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Updated the page from revision v3.0.2 to v3.1.0, signaling a new release version.
    Difference
    0.1%
    Check dated 2025-09-28T03:17:02.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 (replacing v3.0.1) and the Back to Top element was removed; no other substantive changes were observed.
    Difference
    0.2%
    Check dated 2025-09-13T17:40:54.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:23:02.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically adding 'St Louis, Missouri, United States, 63110' and 'eteplirsen' while removing previous mentions of related muscular dystrophy topics.
    Difference
    2%
    Check dated 2025-08-30T12:07:00.000Z thumbnail image

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.